Oracle sued by drug-safety software vendor

Oracle is allegedly in violation of patents held by DrugLogic

Oracle is being sued by drug-safety software vendor DrugLogic over alleged patent violations, according to a complaint filed Dec. 17 in U.S. District Court for the Northern District of California.

DrugLogic makes software for managing clinical drug trials as well as monitoring drugs after they go to market. The suit centers on competing products sold by Relsys and Phase Forward, health care software companies that were acquired by Oracle in March 2009 and April, respectively.

DrugLogic holds U.S. Patent No. 6,789,091 B2, which is titled "Method and System for Web-based Analysis of Drug Adverse Effects," according to the complaint. It was filed in 2001 and awarded in 2004.

The Relsys Argus Perceptive and Phase Forward Empirica Signal applications, which are now owned by Oracle, infringe upon that patent, according to DrugLogic's action.

Oracle, Phase Forward and Relsys were all aware of DrugLogic's patent and infringement claims before the suit was filed, the complaint states

DrugLogic is asking for an injunction barring Oracle from infringing on its patent as well as unspecified compensatory damages.

In addition to the patent infringement claims, DrugLogic is suing for breach of contract in connection with a 2004 co-marketing and development agreement it signed with Relsys. Under the pact, DrugLogic gave Relsys access to confidential information, including "code associated with [its] pharmacovigilance and signal detection tools."

Relsys broke the agreement by failing to keep the data confidential and selling it to third parties, including Oracle, according to the complaint.

Oracle spokeswoman Deborah Hellinger declined comment.

Meanwhile, it seems unlikely that any single legal action will deter Oracle from pursuing future acquisitions in health care and other verticals.

"Vertical expertise will be the key differentiator in the next round of the stack wars," said Ray Wang, CEO and principal analyst of Constellation Research, via e-mail. "Vertical acquisitions provide IP, access to markets, and mindshare."

Chris Kanaracus covers enterprise software and general technology breaking news for The IDG News Service. Chris's e-mail address is Chris_Kanaracus@idg.com

Join the newsletter!

Or

Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

Tags Oraclebusiness issueslegalsoftwareapplicationsintellectual propertypatentPhase ForwardMergers / acquisitionsCivil lawsuitsRelsysDruglogic

Keep up with the latest tech news, reviews and previews by subscribing to the Good Gear Guide newsletter.

Chris Kanaracus

IDG News Service
Show Comments

Brand Post

Most Popular Reviews

Latest Articles

Resources

PCW Evaluation Team

Tom Pope

Dynabook Portégé X30L-G

Ultimately this laptop has achieved everything I would hope for in a laptop for work, while fitting that into a form factor and weight that is remarkable.

Tom Sellers

MSI P65

This smart laptop was enjoyable to use and great to work on – creating content was super simple.

Lolita Wang

MSI GT76

It really doesn’t get more “gaming laptop” than this.

Jack Jeffries

MSI GS75

As the Maserati or BMW of laptops, it would fit perfectly in the hands of a professional needing firepower under the hood, sophistication and class on the surface, and gaming prowess (sports mode if you will) in between.

Taylor Carr

MSI PS63

The MSI PS63 is an amazing laptop and I would definitely consider buying one in the future.

Christopher Low

Brother RJ-4230B

This small mobile printer is exactly what I need for invoicing and other jobs such as sending fellow tradesman details or step-by-step instructions that I can easily print off from my phone or the Web.

Featured Content

Product Launch Showcase

Don’t have an account? Sign up here

Don't have an account? Sign up now

Forgot password?